Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Share (Details)

v3.21.1
Earnings (Loss) Per Share (Details) - $ / shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common stock, par value (in dollars per share) $ 0.01   $ 0.01
Number of common stock warrant and common stock options exercised (in shares) 117,500 0  
Number of common stock issued for stock warrant and stock options exercised (in shares) 117,500 0  
Shares surrendered in lieu of cash payment (in shares) 0    
Common Stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Dilutive potential shares (in shares) 74,623,270 69,339,603